4//SEC Filing
Milligan Sandra 4
Accession 0000950170-24-061083
CIK 0001636282other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:10 PM ET
Size
5.5 KB
Accession
0000950170-24-061083
Insider Transaction Report
Form 4
Milligan Sandra
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-14+21,980→ 21,980 totalExercise: $39.29Exp: 2034-05-14→ Common Stock (21,980 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 21,980 shares of the Issuer's common stock, which will vest and become exercisable in 36 equal monthly installments following May 14, 2024 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001859810
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:10 PM ET
- Size
- 5.5 KB